The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients (ICM)
This study has been terminated.
(We could not recruit patients willing to be enrolled)
Sponsor:
University of California, Davis
Collaborator:
Beth Israel Medical Center
Information provided by (Responsible Party):
George A. Kaysen, M.D., University of California, Davis
ClinicalTrials.gov Identifier:
NCT00529633
First received: September 12, 2007
Last updated: September 25, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |